Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genetic Tech Spn Ads (GENE)

Genetic Tech Spn Ads (GENE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,549
  • Shares Outstanding, K 4,407
  • Annual Sales, $ 20 K
  • Annual Income, $ -4,600 K
  • 60-Month Beta 3.69
  • Price/Sales 445.55
  • Price/Cash Flow N/A
  • Price/Book 6.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.76 +5.11%
on 11/15/19
2.45 -24.49%
on 10/22/19
-0.32 (-14.75%)
since 10/21/19
3-Month
1.70 +8.82%
on 10/11/19
2.85 -35.09%
on 08/23/19
-0.36 (-16.29%)
since 08/21/19
52-Week
1.56 +18.58%
on 08/16/19
6.32 -70.73%
on 05/10/19
-2.47 (-57.18%)
since 11/21/18

Most Recent Stories

More News
Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company"), a diversified molecular diagnostics company, announced today an interview with interim-CEO Dr. Jerzy Muchnicki will air on The RedChip...

GENE : 1.85 (-4.64%)
Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, "Company"), a diversified molecular diagnostics company, announced today an update to shareholders on recent achievements and upcoming milestones.

GENE : 1.85 (-4.64%)
Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests - for Colorectal Cancer and for Breast Cancer

Genetic Technologies Limited (ASX: GTG; NASDAQ Ticker: GENE) is delighted to announce that following substantial scientific research and genetic product development, two new ground-breaking cancer risk...

GENE : 1.85 (-4.64%)
Genetic Technologies Receives Nasdaq Notification Letter

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) announces that it has received a letter from the Nasdaq Stock Market April 29, 2019, advising that the Company's reported...

GENE : 1.85 (-4.64%)
Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding

Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE) ("Company"), a provider of world-leading genetic risk assessment test products, is pleased to announce that it has now established a Memorandum of...

GENE : 1.85 (-4.64%)
Genetic Technologies Asian Operations Established in Hainan, China

Highlights

GENE : 1.85 (-4.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

The current trending strength of the market is Average.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GENE with:

Business Summary

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across...

See More

Key Turning Points

2nd Resistance Point 2.15
1st Resistance Point 2.04
Last Price 1.85
1st Support Level 1.82
2nd Support Level 1.71

See More

52-Week High 6.32
Fibonacci 61.8% 4.50
Fibonacci 50% 3.94
Fibonacci 38.2% 3.38
Last Price 1.85
52-Week Low 1.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar